AU1805799A - Compounds and methods for the detection and prevention of (t. cruzi) infection - Google Patents

Compounds and methods for the detection and prevention of (t. cruzi) infection

Info

Publication number
AU1805799A
AU1805799A AU18057/99A AU1805799A AU1805799A AU 1805799 A AU1805799 A AU 1805799A AU 18057/99 A AU18057/99 A AU 18057/99A AU 1805799 A AU1805799 A AU 1805799A AU 1805799 A AU1805799 A AU 1805799A
Authority
AU
Australia
Prior art keywords
cruzi
infection
prevention
compounds
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU18057/99A
Other languages
English (en)
Inventor
Raymond L. Houghton
Michael J. Lodes
Patricia D. Mcneill
Steven G. Reed
Yasir A.W. Skeiky
John M. Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AU1805799A publication Critical patent/AU1805799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU18057/99A 1997-12-18 1998-12-04 Compounds and methods for the detection and prevention of (t. cruzi) infection Abandoned AU1805799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/993,674 US6228372B1 (en) 1997-04-15 1997-12-18 Compounds and methods for the detection and prevention of T. cruzi infection
US08993674 1997-12-18
PCT/US1998/025871 WO1999031246A1 (en) 1997-12-18 1998-12-04 Compounds and methods for the detection and prevention of t. cruzi infection

Publications (1)

Publication Number Publication Date
AU1805799A true AU1805799A (en) 1999-07-05

Family

ID=25539818

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18057/99A Abandoned AU1805799A (en) 1997-12-18 1998-12-04 Compounds and methods for the detection and prevention of (t. cruzi) infection

Country Status (8)

Country Link
US (1) US6228372B1 (enExample)
EP (1) EP1038000A1 (enExample)
JP (1) JP2002508506A (enExample)
AR (1) AR014132A1 (enExample)
AU (1) AU1805799A (enExample)
BR (1) BR9813637A (enExample)
CO (1) CO4820439A1 (enExample)
WO (1) WO1999031246A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6375955B1 (en) * 1995-09-22 2002-04-23 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6228372B1 (en) 1997-04-15 2001-05-08 Corixa Corporation Compounds and methods for the detection and prevention of T. cruzi infection
US6419933B1 (en) 1995-11-14 2002-07-16 Corixa Corporation Compounds and methods for the detection and prevention of T.cruzi infection
BRPI0618215A2 (pt) * 2005-11-03 2011-08-23 Inbios International Inc polipeptìdeo de fusão, seqüência de polinucleotìdeo isolada, vetor de expressão recombinante, célula hospedeira, método para detectar infecção por t. cruzi em uma amostra biológica, kit para detectar a referida infecção, e composição
US7749717B2 (en) * 2006-10-19 2010-07-06 Abbott Laboratories Methods for the detection and diagnosis of Trypanosoma cruzi infection
US20090203037A1 (en) * 2007-12-27 2009-08-13 Abbott Laboratories Anti-T. Cruzi Antibodies and Methods of Use
EP2291394B1 (en) 2008-07-03 2017-03-15 Infectious Disease Research Institute Fusion proteins and their use in the diagnosis and treatment of leishmaniasis
EP3215849B1 (en) * 2014-11-06 2018-12-19 Roche Diagnostics GmbH Recombinant trypanosoma cruzi jl7 antigen variants and their use for detecting chagas disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870006A (en) 1986-07-24 1989-09-26 Codon Antigenic material for a chagas' disease detection system
WO1990002564A1 (en) 1988-09-12 1990-03-22 Codon Vaccine diagnostic employing proteins homologous to heat shock proteins of trypanosoma cruzi
BR9006039A (pt) 1990-11-28 1992-07-14 Fundacao Oswaldo Cruz Processo para preparacao de antigeno conjugado a atividade enzimatica,composicao a base de conjugado enzima-antigeno para utilizacao em diagnostico imunologico e kits de diagnostico imunologico da doenca de chagas a base da dita composicao,para aplicacao individual e/ou em inqueritos epidemiologicos
US5304371A (en) 1992-02-14 1994-04-19 Lasys Corporation Peptide for diagnosing and immunizing against T. cruzi infection
TW246717B (enExample) 1992-07-10 1995-05-01 Abbott Lab
US5756662A (en) 1995-03-14 1998-05-26 Corixa Corporation Compounds and methods for the detection of T. cruzi infection
US6228372B1 (en) 1997-04-15 2001-05-08 Corixa Corporation Compounds and methods for the detection and prevention of T. cruzi infection
US5916572A (en) 1995-11-14 1999-06-29 Corixa Corporation Compounds and methods for the detection and prevention of T. cruzi infection

Also Published As

Publication number Publication date
WO1999031246A1 (en) 1999-06-24
EP1038000A1 (en) 2000-09-27
BR9813637A (pt) 2001-12-04
CO4820439A1 (es) 1999-07-28
JP2002508506A (ja) 2002-03-19
US6228372B1 (en) 2001-05-08
AR014132A1 (es) 2001-02-07

Similar Documents

Publication Publication Date Title
AU5362696A (en) Compounds and methods for the dectection of t. cruzi infection
AU8908998A (en) Analyte detection systems
AU7688698A (en) Ecg noise detection system
AU5320899A (en) Interference detection and avoidance technique
AU2743197A (en) Sidescatter x-ray detection system
AU7844394A (en) Fluid detection system
AU3737400A (en) Intrusion detection system
AU4282397A (en) Aspirated detector
AU5311699A (en) Optical detection system
AU1917695A (en) Automatic detection of data rate
AU1809597A (en) Obstacle detection system
AU6364699A (en) Detection of analytes
ZA991953B (en) Detection of fermentation-related microorganisms.
AU6264398A (en) Schottky-metal detection method
AU8548498A (en) Enhanced detection method
AUPN952196A0 (en) Blood processing system
AU6407599A (en) Detection processing system
AU1805799A (en) Compounds and methods for the detection and prevention of (t. cruzi) infection
AU4324397A (en) Detection of microorganisms
AU1716001A (en) Detection system
AU2708797A (en) Event detection device
AU3762897A (en) Viral variants and methods for detecting same
AU1820499A (en) Compounds and methods for the diagnosis and treatment of (b. microti) infection
AU6222499A (en) Detection systems
AU8251698A (en) Loop detection

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase